Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15

1.

Enhancing antisense efficacy with multimers and multi-targeting oligonucleotides (MTOs) using cleavable linkers.

Subramanian RR, Wysk MA, Ogilvie KM, Bhat A, Kuang B, Rockel TD, Weber M, Uhlmann E, Krieg AM.

Nucleic Acids Res. 2015 Oct 30;43(19):9123-32. doi: 10.1093/nar/gkv992. Epub 2015 Oct 7.

2.

Differential involvement of p38 mitogen-activated protein kinase kinases MKK3 and MKK6 in T-cell apoptosis.

Tanaka N, Kamanaka M, Enslen H, Dong C, Wysk M, Davis RJ, Flavell RA.

EMBO Rep. 2002 Aug;3(8):785-91. Epub 2002 Jul 15.

3.

Molecular basis of T-cell differentiation.

Flavell RA, Li B, Dong C, Lu HT, Yang DD, Enslen H, Tournier C, Whitmarsh A, Wysk M, Conze D, Rincon M, Davis RJ.

Cold Spring Harb Symp Quant Biol. 1999;64:563-71. Review.

PMID:
11232333
4.

JNK1 is required for T cell-mediated immunity against Leishmania major infection.

Constant SL, Dong C, Yang DD, Wysk M, Davis RJ, Flavell RA.

J Immunol. 2000 Sep 1;165(5):2671-6.

5.

Carbon monoxide has anti-inflammatory effects involving the mitogen-activated protein kinase pathway.

Otterbein LE, Bach FH, Alam J, Soares M, Tao Lu H, Wysk M, Davis RJ, Flavell RA, Choi AM.

Nat Med. 2000 Apr;6(4):422-8.

PMID:
10742149
6.

Defective IL-12 production in mitogen-activated protein (MAP) kinase kinase 3 (Mkk3)-deficient mice.

Lu HT, Yang DD, Wysk M, Gatti E, Mellman I, Davis RJ, Flavell RA.

EMBO J. 1999 Apr 1;18(7):1845-57.

7.

Requirement of mitogen-activated protein kinase kinase 3 (MKK3) for tumor necrosis factor-induced cytokine expression.

Wysk M, Yang DD, Lu HT, Flavell RA, Davis RJ.

Proc Natl Acad Sci U S A. 1999 Mar 30;96(7):3763-8.

8.

Defective T cell differentiation in the absence of Jnk1.

Dong C, Yang DD, Wysk M, Whitmarsh AJ, Davis RJ, Flavell RA.

Science. 1998 Dec 11;282(5396):2092-5.

9.

Targeted disruption of the MKK4 gene causes embryonic death, inhibition of c-Jun NH2-terminal kinase activation, and defects in AP-1 transcriptional activity.

Yang D, Tournier C, Wysk M, Lu HT, Xu J, Davis RJ, Flavell RA.

Proc Natl Acad Sci U S A. 1997 Apr 1;94(7):3004-9.

10.

Molecular cloning of the epidermal growth factor-stimulated protein kinase p56 KKIAMRE.

Taglienti CA, Wysk M, Davis RJ.

Oncogene. 1996 Dec 19;13(12):2563-74.

PMID:
9000130
11.

Genomic loci of human mitogen-activated protein kinases.

Li L, Wysk M, Gonzalez FA, Davis RJ.

Oncogene. 1994 Feb;9(2):647-9.

PMID:
8290275
12.

Isolation of the rat gene for Mullerian inhibiting substance.

Haqq C, Lee MM, Tizard R, Wysk M, DeMarinis J, Donahoe PK, Cate RL.

Genomics. 1992 Apr;12(4):665-9.

PMID:
1572639
13.

Cloning of murine and rat vascular cell adhesion molecule-1.

Hession C, Moy P, Tizard R, Chisholm P, Williams C, Wysk M, Burkly L, Miyake K, Kincade P, Lobb R.

Biochem Biophys Res Commun. 1992 Feb 28;183(1):163-9.

PMID:
1371918
14.

Genomic Southern analysis with alkaline-phosphatase-conjugated oligonucleotide probes and the chemiluminescent substrate AMPPD.

Cate RL, Ehrenfels CW, Wysk M, Tizard R, Voyta JC, Murphy OJ 3rd, Bronstein I.

Genet Anal Tech Appl. 1991 May;8(3):102-6.

PMID:
1905941
15.

Imaging of DNA sequences with chemiluminescence.

Tizard R, Cate RL, Ramachandran KL, Wysk M, Voyta JC, Murphy OJ, Bronstein I.

Proc Natl Acad Sci U S A. 1990 Jun;87(12):4514-8.

Supplemental Content

Support Center